These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Treatment of neurogenic orthostatic hypotension with amezinium metilsulfate, a new indirect sympathomimetic drug. Kita K; Hirayama K Neurology; 1988 Jul; 38(7):1095-9. PubMed ID: 3386828 [TBL] [Abstract][Full Text] [Related]
45. Treatment of severe orthostatic hypotension with the somatostatin analogue octreotide. Woo J; Or KH; Teoh R; Nicholls MG Aust N Z J Med; 1990 Dec; 20(6):822-3. PubMed ID: 2291734 [TBL] [Abstract][Full Text] [Related]
46. [Postural hypotension]. Sivertssen E Tidsskr Nor Laegeforen; 1967 Oct; 87(20):Suppl:1765-9. PubMed ID: 5591133 [No Abstract] [Full Text] [Related]
47. Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome. Goovaerts J; Verfaillie C; Fagard R; Knockaert D Br Med J (Clin Res Ed); 1984 Mar; 288(6420):817-8. PubMed ID: 6142747 [TBL] [Abstract][Full Text] [Related]
48. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease. Kremens D; Lew M; Claassen D; Goodman BP Clin Auton Res; 2017 Jul; 27(Suppl 1):29-31. PubMed ID: 28674867 [No Abstract] [Full Text] [Related]
49. [A combined therapy with yohimbine and fludrocortisone in idiopathic orthostatic hypotension. A case report]. Touma T; Muratani H; Takishita S; Fukiyama K Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):988-9. PubMed ID: 2794688 [No Abstract] [Full Text] [Related]
50. [Treatment of neurogenic orthostatic hypotension by an association of tyramine and a monoamine oxidase inhibitor (author's transl)]. Guillevin L; Dumas P; Bletry O; Serdaru M; Brunet P; Godeau P Ann Med Interne (Paris); 1980; 131(8):504-7. PubMed ID: 7013600 [TBL] [Abstract][Full Text] [Related]
51. [Therapy of orthostatic disorders of cardiovascular regulation. Placebo controlled double-blind study with oxilofrine]. Pohl K; Kriech W Fortschr Med; 1991 Nov; 109(33):685-8. PubMed ID: 1769643 [TBL] [Abstract][Full Text] [Related]
52. Combined phenylephrine and tranylcypromine for postural hypotension. Itskovitz HD; Wartenburg A Am Heart J; 1983 Sep; 106(3):598-9. PubMed ID: 6881039 [No Abstract] [Full Text] [Related]
54. Idiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report. Sharpe J; Marquez-Julio A; Ashby P Can Med Assoc J; 1972 Aug; 107(4):296-300. PubMed ID: 5056115 [TBL] [Abstract][Full Text] [Related]
55. Midodrine in neurogenic orthostatic hypotension. A new treatment. Gilden JL Int Angiol; 1993 Jun; 12(2):125-31. PubMed ID: 7690383 [TBL] [Abstract][Full Text] [Related]
56. [Letter: A severe case of postural hypotension. Paradoxical treatment by L-dopa combined with an inhibitor of extracerebral dopa-decarboxylase]. Boismare F; Boquet J Nouv Presse Med; 1975 Feb; 4(8):589. PubMed ID: 1129119 [No Abstract] [Full Text] [Related]
57. [Therapy of age-induced hypotension and hypotensive orthostatic regulation disorders using Regulton]. Harwart D Fortschr Med; 1983 Jan; 101(3):94-8. PubMed ID: 6826139 [No Abstract] [Full Text] [Related]
58. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. Chobanian AV; Volicer L; Tifft CP; Gavras H; Liang CS; Faxon D N Engl J Med; 1979 Jul; 301(2):68-73. PubMed ID: 449947 [TBL] [Abstract][Full Text] [Related]
59. Etilefrine in the treatment of levodopa-induced orthostatic hypotension. Miller E; Wiener L; Bloomfield D Arch Neurol; 1973 Aug; 29(2):99-103. PubMed ID: 4577820 [No Abstract] [Full Text] [Related]
60. Diversity in supercoupling of beta 2-adrenergic receptors in orthostatic hypotension. Mares A; Davies AO; Taylor AA Clin Pharmacol Ther; 1990 Mar; 47(3):371-81. PubMed ID: 2155734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]